Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

182.91
Delayed Data
As of 3:59pm ET
 +1.62 / +0.89%
Today’s Change
150.06
Today|||52-Week Range
209.22
+7.35%
Year-to-Date
BioCryst Pill Prevents Swelling Attacks but Shares Fall on Competitive Concerns
10:10am / TheStreet.com - Paid Partner Content
3 Stocks to Invest in Big Pharma
Feb 20 / MotleyFool.com - Paid Partner Content
Biotech Movers: Shire Rises on Encouraging Angioedema Results
Feb 23 / TheStreet.com - Paid Partner Content
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Bioscienc...
Feb 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close181.29
Today’s open180.25
Day’s range179.91 - 183.10
Volume49,813
Average volume (3 months)1,262,612
Market cap$54.7B
Dividend yield0.44%
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+14.68%
Earnings growth (next 5 years)+13.39%
Revenue growth (last year)+76.71%
P/E ratio79.1
Price/Sales3.89
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.13+0.38%
REGNRegeneron Pharmaceut...+12.20+3.38%
AZNAstraZeneca+0.01+0.05%
ABTAbbott Laboratories-0.22-0.48%
Data as of 3:59pm ET, 02/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$3.47
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs